| Filed On | Filing |
|---|---|
| 27 Oct 2026 | SCHEDULE 13G/A |
| 20 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
______________________________________________________________________________ |
| 09 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
This Separation Agreement and Release of Claims (“Agreement”) is entered into by and between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”) and Brian Donnelly (“Executive” and to... |
| 22 Sep 2026 |
Form 4: Wheeler Benjamin Richard, Chief Financial Officer
Gave up 2,555 shares to cover exercise price or tax ($10.2K) |
| 18 Sep 2026 |
Form 4: Donnelly Brian J, Chief Commercial Officer
Holds 573,363 shares of Common Stock |
| 17 Sep 2026 |
Form 4: Sikri Vishal, EVP, Commercial
Received 257,731 shares as a grant or award |
| 17 Sep 2026 |
Form 3: Sikri Vishal, EVP, Commercial
Holds 93,493 shares of Common Stock |
| 16 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
SALT LAKE CITY, September 16, 2026 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Vishal Sikri has been promoted to Executive Vice President - Commercial, ef... |
| 08 Sep 2026 |
Form 4: Fox Jennifer Lynne, Chief Legal Officer
Gave up 4,398 shares to cover exercise price or tax ($14.2K) |
| 04 Sep 2026 | SCHEDULE 13G |
| 17 Aug 2026 |
Form 4: Wheeler Benjamin Richard, Chief Financial Officer
Gave up 8,761 shares to cover exercise price or tax ($26.5K) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G |
| 07 Aug 2026 | SCHEDULE 13G |
| 31 Jul 2026 | 10-Q |
| 30 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 23 Jun 2026 |
Form 4: Skovronsky Daniel, Director
Holds 195,507 shares of Common Stock |
| 23 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 12 Jun 2026 |
Form 4: Raha Samraat S., Director
Received 3,542 shares as a grant or award ($13.9K) |
| 12 Jun 2026 |
Form 4: Donnelly Brian J, Chief Commerical Officer
Received 5,000 shares as a grant or award ($19.7K) |
Loading...
